An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases

Clinical trial NCT04950114 · TERMINATED

Trial details

NCT number: NCT04950114
Sponsor: Goldfinch Bio, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Kidney Diseases Glomerulosclerosis Focal Segmental Nephrosis Lipoid Urologic Disease Glomerulonephritis Nephritis Nephrosis

Start date: 2021-07-27
Primary completion: 2022-11-02
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.